Alvotech (ALVO) Total Current Liabilities (2020 - 2026)
Alvotech's (ALVO) quarterly Total Current Liabilities came in at $259.8 million in Q1 2026, down 2.27% YoY from $265.8 million in Q1 2025, and down 14.57% on a QoQ basis from $304.1 million in Q4 2025.
Alvotech (ALVO) Total Current Liabilities (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Total Current Liabilities data on file, last reported at $259.8 million in Q1 2026.
- Quarterly Total Current Liabilities fell 2.27% year-over-year to $259.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $259.8 million (down 2.27% YoY) and the FY2025 annual result came in at $304.1 million, up 57.23% from the prior year.
- Total Current Liabilities declined to $259.8 million in Q1 2026, from $304.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.2 billion in Q2 2024 to a low of $160.3 million in Q1 2023.
- A 5-year average of $307.5 million and a median of $260.4 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities surged 442.4% — and 2025, when it tumbled 76.74%.
- Tracing ALVO's Total Current Liabilities over 5 years: stood at $167.3 million in 2022, then jumped by 55.98% to $261.0 million in 2023, then dropped by 25.89% to $193.4 million in 2024, then jumped by 57.23% to $304.1 million in 2025, then dropped by 14.57% to $259.8 million in 2026.
- The last three Total Current Liabilities figures came in at $259.8 million (Q1 2026), $304.1 million (Q4 2025), and $304.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | 259.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 259.78 Mn |
| Dec 31, 2025 | 304.08 Mn |
| Sep 30, 2025 | 304.07 Mn |
| Jun 30, 2025 | 279.75 Mn |
| Mar 31, 2025 | 265.81 Mn |
| Dec 31, 2024 | 193.40 Mn |
| Sep 30, 2024 | 160.55 Mn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 246.79 Mn |
| Dec 31, 2023 | 260.95 Mn |
| Jun 30, 2023 | 221.69 Mn |
| Mar 31, 2023 | 160.33 Mn |
| Dec 31, 2022 | 167.29 Mn |
| Jun 30, 2022 | 277.79 Mn |
| Dec 31, 2021 | 111.84 Mn |
| Dec 31, 2020 | 50.98 Mn |